Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to Vitamin K antagonists

Thrombosis Research

Volumn 136, Issue 4, 2015, Pages 749-753

  De Crem, Nico ^a   Peerlinck, Kathelijne ^a   Vanassche, Thomas ^a   Vanheule, Kristine ^a   Debaveye, Barbara ^a   Middeldorp, Saskia ^b   Verhamme, Peter ^a   Peetermans, Marijke ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Abnormal uterine bleeding; Anticoagulants; Menstruation; Rivaroxaban; Venous thromboembolism; Vitamin K antagonist

Indexed keywords

ANTIVITAMIN K; RIVAROXABAN; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ABNORMAL UTERINE BLEEDING; ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONSULTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS BLEEDING; VENOUS THROMBOEMBOLISM; ANTAGONISTS AND INHIBITORS; RISK FACTOR; UTERINE HEMORRHAGE; YOUNG ADULT;

ADULT; ANTICOAGULANTS; FEMALE; HUMANS; RETROSPECTIVE STUDIES; RISK FACTORS; RIVAROXABAN; UTERINE HEMORRHAGE; VENOUS THROMBOEMBOLISM; VITAMIN K; YOUNG ADULT;

EID: 84941876034     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.07.030     Document Type: Article

References (18)

1. L.A. Heinemann, and J.C. Dinger Range of published estimates of venous thromboembolism incidence in young women Contraception 75 2007 328 336
2. J.P. Vandenbroucke, J. Rosing, K.W. Bloemenkamp, S. Middeldorp, F.M. Helmerhorst, B.N. Bouma, and et al. Oral contraceptives and the risk of venous thrombosis N. Engl. J. Med. 344 2001 1527 1535
3. P.S. Wells, M.A. Forgie, and M.A. Rodger Treatment of venous thromboembolism JAMA 311 2014 717 728 10.1001/jama.2014.65
4. N. van Es, M. Coppens, S. Schulman, S. Middeldorp, and H.R. Buller Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Blood 124 2014 1968 1975 10.1182/blood-2014-04-571232
5. E.I.N.S.T.E.I.N. Investigators, R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, A.S. Gallus, and et al. Oral rivaroxaban for symptomatic venous thromboembolism N. Engl. J. Med. 363 2010 2499 2510 10.1056/NEJMoa1007903
6. E.I.N.S.T.E.I.N.-P.E. Investigators, H.R. Buller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, E. Minar, and et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N. Engl. J. Med. 366 2012 1287 1297 10.1056/NEJMoa1113572
7. M.H. Prins, A.W. Lensing, R. Bauersachs, B. van Bellen, H. Bounameaux, T.A. Brighton, and et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies Thromb. J. 11 2013 21 10.1186/1477-9560-11-21
8. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N. Engl. J. Med. 365 2011 883 891 10.1056/NEJMoa1009638
9. T. Vanassche, J. Hirsh, J.W. Eikelboom, and J.S. Ginsberg Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials Thromb. Haemost. 112 2014 918 923 10.1160/TH14-04-0346
10. P.S. Wells, D.R. Anderson, J. Bormanis, F. Guy, M. Mitchell, L. Gray, and et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management Lancet 350 1997 1795 1798
11. P.S. Wells, D.R. Anderson, M. Rodger, J.S. Ginsberg, C. Kearon, M. Gent, and et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer Thromb. Haemost. 83 2000 416 420
12. I.S. Fraser, H.O. Critchley, M. Broder, and M.G. Munro The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding Semin. Reprod. Med. 29 2011 383 390 10.1055/s-0031-1287662
13. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers WHO/NHD/013 2001 World Health Organization Geneva
14. F.Y. Huq, K. Tvarkova, A. Arafa, and R.A. Kadir Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation Contraception 84 2011 128 132 10.1016/j.contraception.2010.12.011
15. A. Sjalander, B. Friberg, P. Svensson, L. Stigendal, and S. Lethagen Menorrhagia and minor bleeding symptoms in women on oral anticoagulation J. Thromb. Thrombolysis 24 2007 39 41
16. L. Loffredo, L. Perri, and F. Violi Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials Dig. Liver Dis. 47 2015 429 431 10.1016/j.dld.2015.01.159
17. I.L. Holster, V.E. Valkhoff, E.J. Kuipers, and E.T. Tjwa New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis Gastroenterology 145 2013 105 112 10.1053/j.gastro.2013.02.041 (e15)
18. I. Martinelli, A.W. Lensing, J. Beyer-Westendorf, M. Trajanovic, M. Gebel, P. Lam, and M.H. Prins Hormonal therapy and the risk of recurrent venous thromboembolism in women receiving anticoagulant treatment Abstracts. J. Thromb. Haemost. 13 S2 2015 8 10.1111/jth.12993